ENLV: Enlivex Therapeutics Ltd Company Short-Term Debt
Renowned scientists within the leadership of Enlivex Therapeutics (ENLV) guarantee trial transparency and strict adherence to protocols. The volume of short-term borrowed capital reflects solvency dynamics, where the 0.00 metric determines this level. Management is implementing innovations in the treatment of sepsis and cancer, establishing new therapy standards. However, the lack of internal cash flow makes development dependent on external financing.
Metric breakdowns and analytics for Enlivex Therapeutics Ltd (ENLV)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Enlivex Therapeutics|ENLV - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Enlivex Therapeutics, Ltd.|ENLV - Company Total Debt|Debt to Book Capitalization Ratio Enlivex Therapeutics Ltd.|ENLV - Company Long-Term Liabilities|Company Current Liabilities Enlivex Therapeutics|Quick Liquidity enlivex.com
- net income and valuation multiples indicators:
Initial company analysis:ENLV - enlivex.com
This indicator measures the current load of obligations maturing within one year, allowing for an assessment of liquidity risk and the cost of debt service amid rate volatility. The current value of 0.00 demonstrates the financial stability of Enlivex Therapeutics (ENLV) as it develops a unique macrophage reprogramming system to combat sepsis, which clearly reflects the short-term debt trend.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Short-Term Debt Zenas Corp|Immunome, Inc. (IMNM) - Company Short-Term Debt|Company Short-Term Indebtedness GOSS|Company Short-Term Debt KalVista Pharmaceuticals, Inc.|Company Short-Term Debt SEPN|Company Short-Term Debts PVLA|Short-Term Debt Volume Savara Pharma|Rigel Pharmaceuticals - Company Current Liabilities|anaptysbio.com - Company Short-Term Debt|Astria Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt enGene Holdings Inc|RAPT (RAPT Therapeutics) - Company Current Liabilities|Company Short-Term Indebtedness JBIO|Company Current Liabilities ACRS|KYTX: Company Short-Term Loans and Borrowings|Company Current Liabilities TLSA (Tiziana Life Sciences Ltd)|Amount of Current Liabilities CABA|Company Short-Term Debts VTYX (Ventyx Bio)|Company Short-Term Loans and Borrowings THTX|Avalo Therapeutics, Inc - Company Short-Term Debts|Short-Term Debt eledon.com|Agenus Inc. (AGEN) - Company Short-Term Debt|Climb Bio Inc. - Company Short-Term Loans and Borrowings|ZURA (Zura Bio) - Company Short-Term Debts|Company Short-Term Debts aTyr Pharmaceuticals|Company Short-Term Debt Adagene (ADAG)|IMA: Current Liabilities|Company Short-Term Debts STTK (Shattuck Labs)|Equillium Inc (EQ) - Short-Term Debt|CNTB: Company Current Liabilities|IMUX - Company Short-Term Debts|ATRA (atarabio.com) - Company Current Liabilities|IFRX: Amount of Current Liabilities|XFOR (X4 Pharmaceuticals, Inc.) - Company Short-Term Debts|Adicet (ACET) - Short-Term Debt Volume|Company Short-Term Debts CELU|Company Current Liabilities INmune Bio Corporation INMB|Company Short-Term Debt Barinthus Biotherapeutics BRNS|Short-Term Debt Volume kezarlifesciences.com (KZR)|SAB Biotherapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Akari Therapeutics PLC|q32bio.com (QTTB) - Company Short-Term Debt|Company Short-Term Indebtedness GOVX|Company Short-Term Debt Edesa Biotech, Inc.|Company Short-Term Debt IBIO|Company Current Liabilities CARM (Carisma Therapeutics)|Company Short-Term Debt XTLB (XTL Biopharmaceuticals Ltd)|Company Short-Term Debt Bolt Biotherapeutics, Inc. BOLT|HCWB (HCW Biologics, Inc.) - Current Liabilities|Aptevo - Company Short-Term Debts|Company Short-Term Loans and Borrowings AIM (aimimmuno.com)|ADTX: Company Short-Term Debts|GRI Bio Inc (GRI) - Company Short-Term Debts|Company Short-Term Debt XORTX|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debt Revelation Biosciences (REVB)|Company Current Liabilities indaptusrx.com INDP|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Company Short-Term Debts CalciMedica Inc CALI|AFMD: Company Current Liabilities|Company Short-Term Loans and Borrowings ALLK (Allakos Inc.)|HOOK: Company Short-Term Debts|IGMS - Short-Term Debt Volume|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD